Pegasus Mercantile Inc. is a Canada-based prospect generator that provides companies with technology, financial, operational, and management assistance in the market for global wellness products and novel consumer goods and services. The Company is focused on hemp, cannabidiol (CBD), related, functional mushrooms, psilocybin plus other psychedelics, helping companies create sustainable products that elevate their personal health and wellbeing. It is focused on the specific areas of pain, depression and mental illness. By investing in pioneering techniques, such as micro-dosing using organic compounds and synthetic molecules. It is transforming the treatment of chronic pain, psychiatric ailments and depression by pioneering trials of fixed-dose drugs, combining psilocybin, ketamine, and MDMA, embracing the endless possibilities of micro-dosing. It has 100% interest in Shanti Therapeutics Pty Ltd. (Shanti), which is focused on psychedelic MDMA-based drug development research.